Results 161 to 170 of about 252,165 (283)
NCMP-14. TREATMENT RESPONSE OF LEPTOMENINGEAL CARCINOMATOSIS IN CLL: A CASE REPORT AND REVIEW OF THE LITERATURE [PDF]
, 2018 Alipi V. Naydenov, Lynne P. Taylor
openalex +1 more source
Cancer Medicine, Volume 15, Issue 2, February 2026.ABSTRACT Purpose To determine whether adolescent and young adults (AYA) with Hodgkin lymphoma (HL) who are treated by oncologists with “AYA expertise” improve outcomes. Methods All AYA aged 15–21 years diagnosed with HL in Ontario, Canada between 1992 and 2012 were identified, and clinical data abstracted as part of the IMPACT cohort.
Eden C. Andrew +5 more
wiley +1 more source
Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation [PDF]
, 2023 Karoline Kielbassa +10 more
openalex +1 more source
Function of B-Cell CLL/Lymphoma 11B in Glial Progenitor Proliferation and Oligodendrocyte Maturation
, 2018 Chih-Yen Wang +5 more
openalex +1 more source
Minimal residual disease in solid tumors: Clinical applications and future directions
Cancer, Volume 132, Issue 3, 1 February 2026.Abstract Minimal residual disease (MRD) refers to the presence of residual cancer cells or tumor‐derived fragments that persist after treatment and remain undetectable by conventional imaging or protein‐based assays. Circulating tumor DNA (ctDNA) has emerged as a dynamic biomarker for MRD detection.
Theresa Abdo +8 more
wiley +1 more source
An unusual presentation of Chronic Lymphocytic Leukaemia as delirium
Archives of Mental Health, 2017 Delirium is a state of impairment in the level of consciousness, cognition, psychomotor activity, sleep-wake cycle and emotions. It is one of the most common neuropsychiatric complication in terminally ill cancer patients. People with Chronic Lymphocytic
N Manamohan +3 more
doaj
Cancer Reports, Volume 9, Issue 2, February 2026.ABSTRACT Background Acute myeloid leukemia (AML) is a prevalent hematologic malignancy in adults, marked by clonal disorders in hematopoietic cells, rapid progression, and genetic heterogeneity. The WRAP53 gene, which is associated with genomic stability due to its involvement in activities, such as DNA repair, TP53 regulation, and association with ...
Renan Brito Gadelha +14 more
wiley +1 more source
Overcoming challenges in CAR‐T therapy for malignancies: Mechanisms and strategies
Clinical and Translational Discovery, Volume 6, Issue 1, February 2026.Chimeric antigen receptor T (CAR‐T) cell therapy faces three major challenges: tumour‐intrinsic resistance mechanisms, limitations in CAR‐T cell efficacy and immunosuppressive tumour microenvironment (TME) effects. Emerging strategies address these hurdles through precision targeting enhancement, optimised CAR‐T cell persistence/functionality and TME ...
Yushan Huang +7 more
wiley +1 more source